Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hypercholesterolemia:
Design and rationale of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial
To access this article, please choose from the options below
PII: S0002-8703(04)00550-2
doi:10.1016/j.ahj.2004.06.024
© 2005 Elsevier Inc. All rights reserved.
